New Leaf Venture Partners is a venture capital firm that invests primarily in healthcare technology. The company typically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.
The New Leaf Ventures (NLV) team has been built over a decade, originating within Sprout Group, the
venture capital affiliate of Credit Suisse First Boston. Sprout Group was formed in 1969 and has historically been one of the leading venture capital firms in the country. The team started to invest in healthcare technology in 1993 and since then, has become a leading venture investor in that sector. In 2005, the entire healthcare technology team of Sprout spun out into NLV.
Website:www.nlvpartners.com
Industries:
Biotechnology
Health Care
Medical
Cyber Security
Data Visualization
Hospital
Software
Medical Device
Apps
Artificial Intelligence
Education
Information Technology
Neuroscience
Therapeutics
Biopharma
Collaboration
Compliance
Enterprise
Enterprise Software
mHealth
Productivity Tools
SaaS
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
New York City, New York, United States
Contact information: